Private View: Discussing Women's Health

Share this article:
Private View: Discussing Women's Health
Dan Chichester

Hot flashes, weight gain, intimacy issues: these are old friends. Am I oversharing? The fact is that menopause and women's health was my entrée into healthcare. Helping evolve the Knowmenopause website also evolved my POV, as an ad professional—and as a human being. Learning medical details was “easy.” What confounded me was the tone-deaf surround-sound confronting too many women, from society… and even some health pros: “It's the same for everyone, honey, so deal!” Suddenly, I wasn't crafting clever promotions for B2B tech or 3-in-1 cable service. Now I had a responsibility to, and increasing respect for, individuals who were confronting this change—indeed, “The Change”—in their bodies and lives.

Even as I've engaged with other serious conditions, those first lessons stay with me. An opportunity to revisit the field, even through others' eyes, is a chance to reflect, anew, on what should drive all our contributions to an active health dialogue.

Here's to responsibility and respect…

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.